Former Insys CEO says Founder Pushed Fentanyl Sales On Doctors

Download Audio

A major federal trial involving the pharmaceutical company Insys and the opioid crisis is at a crucial point in Boston federal court. John Kapoor, the founder of the Arizona-based company, is accused of a major kickback scheme to push a highly addictive spray form of fentanyl.

On Wednesday, former Insys CEO Michael Babich, who has already pleaded guilty in the case, claimed Kapoor encouraged sales reps to reward doctors who prescribed the spray more often and at higher doses.

Aaron Leibowitz, who covers the Boston courts for Law360, joined Morning Edition to talk about the case.

This segment aired on February 14, 2019.

Headshot of Bob Oakes

Bob Oakes Senior Correspondent
Bob Oakes was a senior correspondent in the WBUR newsroom, a role he took on in 2021 after nearly three decades hosting WBUR's Morning Edition.



More from WBUR

Listen Live